GlycoMimetics Competitors, Revenue, Alternatives and Pricing

Claim your profile


Total Funding:$101.8M
Lead Investor(s):Jefferies, Cowen

Estimated Revenue & Financials

  • GlycoMimetics's estimated annual revenue is currently $8.4M per year.(?)
  • GlycoMimetics received $119.0M in venture funding in March 2018.
  • GlycoMimetics's estimated revenue per employee is $138,393
  • GlycoMimetics's total funding is $101.8M.

Employee Data

  • GlycoMimetics has 61 Employees.(?)
  • GlycoMimetics grew their employee count by -2% last year.
  • GlycoMimetics currently has 1 job openings.

At GlycoMimetics, we are committed to helping to make a difference in the lives of people living with sickle cell, cancer, and other serious diseases. Our mission is to continue to advance our research and clinical candidates, providing hope for patients as we strive for tomorrow's breakthrough treatments. GlycoMimetics is a clinical-stage biotechnology company. We use novel and proprietary glycobiology technology to develop treatments for diseases, particularly where there is high unmet need. Since the company's inception in 2003, we have developed a robust, diversified product pipeline. We are a public company traded on the NASDAQ under the symbol GLYC.

keywords:Biotechnology,Cleantech,Healthcare,Pharmaceuticals,Wind Power